Patents by Inventor Germain MARGALL DUCOS

Germain MARGALL DUCOS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CD96-BINDING AGENTS AS IMMUNOMODULATORS
    Publication number: 20230192845
    Abstract: Provided is a CD96-binding agent, wherein the agent is capable of stimulating activation and/or proliferation of T cells upon binding to CD96. Also provided are isolated nucleic acids and cells that produce the agent and uses thereof.
    Type: Application
    Filed: August 10, 2018
    Publication date: June 22, 2023
    Applicants: BLINK BIOMEDICAL SAS, TALIX THERAPEUTICS NV
    Inventors: Florence Renart-Depontieu, Sachiko Takami, Germain Margall-Ducos, Nicola Beltraminel-Li, Pierre Garrone, Anne Rogel, Aymen Al-Shamkhani, Xavier Preville
  • ANTI-GALECTIN-9 ANTIBODY AND USES THEREOF
    Publication number: 20230054718
    Abstract: The invention provides humanized monoclonal antibodies against Gal9, and method of using the antibodies to treat cancer, including combination therapy with antagonists of the PD-1/PD-L1 immune checkpoint.
    Type: Application
    Filed: January 6, 2021
    Publication date: February 23, 2023
    Applicant: HiFiBio (HK) Limited
    Inventors: Germain MARGALL DUCOS, Rachel PACHERIE, Nicola Arturo Aldo BELTRAMINELLI, Francisco ADRIAN, Liang SCHWEIZER, Muriel DAVID, Yun-Yueh LU